Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279955 · ClinicalTrials.gov registry record
PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 1,024
- Enrollment target
NCT00279955 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,024 participants.
The verdict
NCT00279955 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 1,024 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart failure related adverse events and health care utilization.
Interventions
- DEVICE Cardiac Resynchronization Therapy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,024 participants |
| Start Date | 2004-06 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279955
The ClinicalTrials.gov registry entry for NCT00279955 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,024 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy Device is the first listed.
NCT00279955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00279955 about?
NCT00279955 is a clinical study titled "PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure". The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart failure related adverse events and health care utilization.
What is the current status of trial NCT00279955?
This trial is currently completed. The enrollment target is 1,024 participants. The study started on 2004-06. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00279955?
The interventions under investigation include: Cardiac Resynchronization Therapy Device (DEVICE).
Who is sponsoring clinical trial NCT00279955?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.